Literature DB >> 18480244

Mast cell-dependent anorexia and hypothermia induced by mucosal activation of Toll-like receptor 7.

Tomoko Hayashi1, Howard B Cottam, Michael Chan, Guangyi Jin, Rommel I Tawatao, Brian Crain, Lisa Ronacher, Karen Messer, Dennis A Carson, Maripat Corr.   

Abstract

Systemic viral infections produce a highly regulated set of responses in sickness behavior, such as fever, anorexia, and adipsia. Toll-like receptor (TLR)7, activated by viral RNA during infection, potently stimulates the innate and adaptive immune responses that aid in viral clearance. However, the physiological consequences of TLR7 activation have not been thoroughly studied. In these experiments, we used a potent synthetic TLR7 ligand, 9-benzyl-8-hydroxy-2-(2-methoxyethoxy)adenine (SM360320; 1V136), to investigate the consequences of TLR7 activation in genetically defined strains of mice. Administration of the drug by the nasal, intragastric, or intraperitoneal routes caused transient hypophagia, hypodypsia, and hypothermia. Analyses of mutant mouse strains indicated that these effects were dependent on the expression of TLR7, its adaptor protein MyD88, and TNF-alpha, and independent of IL-1beta, IL-6 and cyclo-oxygenase-1 (COX1). Partial roles were also implied for mast cells and COX2. Although plasma TNF-alpha levels were significantly higher after systemic drug delivery, the behavioral effects were maximal when the agent was administered to the mucosa. Tissue and mucosal mast cells are known to express high levels of TLR7 and to rapidly release TNF-alpha upon TLR7 ligation. Mice deficient in tissue mast cells, W/W(v), had significantly less anorexia after TLR7 activation, and this response was restored with mast cell reconstitution. Our results thus suggest that tissue mast cells may play a role in the anorexia induced by mucosal activation of TLR7.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480244      PMCID: PMC2494819          DOI: 10.1152/ajpregu.00527.2007

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  60 in total

Review 1.  Behavioral effects of cytokines.

Authors:  S J Larson; A J Dunn
Journal:  Brain Behav Immun       Date:  2001-12       Impact factor: 7.217

Review 2.  CpG DNA in the prevention and treatment of infections.

Authors:  Alexander Dalpke; Stefan Zimmermann; Klaus Heeg
Journal:  BioDrugs       Date:  2002       Impact factor: 5.807

Review 3.  Cytokine-induced sickness behavior: mechanisms and implications.

Authors:  R Dantzer
Journal:  Ann N Y Acad Sci       Date:  2001-03       Impact factor: 5.691

4.  Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

Authors:  Keith B Gorden; Kevin S Gorski; Sheila J Gibson; Ross M Kedl; William C Kieper; Xiaohong Qiu; Mark A Tomai; Sefik S Alkan; John P Vasilakos
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

5.  Discovery of 8-hydroxyadenines as a novel type of interferon inducer.

Authors:  Kosaku Hirota; Kazunori Kazaoka; Itaru Niimoto; Hiroshi Kumihara; Hironao Sajiki; Yoshiaki Isobe; Haruo Takaku; Masanori Tobe; Haruhisa Ogita; Tetsuhiro Ogino; Shinji Ichii; Ayumu Kurimoto; Hajime Kawakami
Journal:  J Med Chem       Date:  2002-12-05       Impact factor: 7.446

6.  COX-2 inhibition attenuates anorexia during systemic inflammation without impairing cytokine production.

Authors:  Paulette M Johnson; Sherri K Vogt; Mary W Burney; Louis J Muglia
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-03       Impact factor: 4.310

7.  A role for cyclooxygenase-2 in lipopolysaccharide-induced anorexia in rats.

Authors:  F Lugarini; B J Hrupka; G J Schwartz; C R Plata-Salaman; W Langhans
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-10       Impact factor: 3.619

8.  Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines.

Authors:  Steven E Applequist; Robert P A Wallin; Hans-Gustaf Ljunggren
Journal:  Int Immunol       Date:  2002-09       Impact factor: 4.823

9.  Behavioral characterization of mice lacking histamine H(3) receptors.

Authors:  Hiroshi Toyota; Christine Dugovic; Muriel Koehl; Aaron D Laposky; China Weber; Karen Ngo; Ying Wu; Doo Hyun Lee; Kazuhiko Yanai; Eiko Sakurai; Takehiko Watanabe; Changlu Liu; Jingcai Chen; Ann J Barbier; Fred W Turek; Wai-Ping Fung-Leung; Timothy W Lovenberg
Journal:  Mol Pharmacol       Date:  2002-08       Impact factor: 4.436

10.  Distinct roles for cyclooxygenases 1 and 2 in interleukin-1-induced behavioral changes.

Authors:  Artur H Swiergiel; Adrian J Dunn
Journal:  J Pharmacol Exp Ther       Date:  2002-09       Impact factor: 4.030

View more
  18 in total

1.  Intravesical Toll-like receptor 7 agonist R-837: optimization of its formulation in an orthotopic mouse model of bladder cancer.

Authors:  Tomoko Hayashi; Brian Crain; Maripat Corr; Michael Chan; Howard B Cottam; Roberto Maj; Alcide Barberis; Lorenzo Leoni; Dennis A Carson
Journal:  Int J Urol       Date:  2010-03-11       Impact factor: 3.369

2.  Cutting edge: nitrogen bisphosphonate-induced inflammation is dependent upon mast cells and IL-1.

Authors:  John T Norton; Tomoko Hayashi; Brian Crain; John S Cho; Lloyd S Miller; Maripat Corr; Dennis A Carson
Journal:  J Immunol       Date:  2012-03-02       Impact factor: 5.422

Review 3.  Immune-neural connections: how the immune system's response to infectious agents influences behavior.

Authors:  Robert H McCusker; Keith W Kelley
Journal:  J Exp Biol       Date:  2013-01-01       Impact factor: 3.312

4.  Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7.

Authors:  Tomoko Hayashi; Christine S Gray; Michael Chan; Rommel I Tawatao; Lisa Ronacher; Maureen A McGargill; Sandip K Datta; Dennis A Carson; Maripat Corr
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

5.  Knockout of the Trpc1 gene reveals that TRPC1 can promote recovery from anaphylaxis by negatively regulating mast cell TNF-α production.

Authors:  Nevenka Medic; Avanti Desai; Ana Olivera; Joel Abramowitz; Lutz Birnbaumer; Michael A Beaven; Alasdair M Gilfillan; Dean D Metcalfe
Journal:  Cell Calcium       Date:  2013-03-13       Impact factor: 6.817

6.  Innate immune protection against infectious diseases by pulmonary administration of a phospholipid-conjugated TLR7 ligand.

Authors:  Christina C N Wu; Brian Crain; Shiyin Yao; Mojgan Sabet; Fitzgerald S Lao; Rommel I Tawatao; Michael Chan; Donald F Smee; Justin G Julander; Howard B Cottam; Donald G Guiney; Maripat Corr; Dennis A Carson; Tomoko Hayashi
Journal:  J Innate Immun       Date:  2013-11-01       Impact factor: 7.349

7.  Persistent Toll-like receptor 7 stimulation induces behavioral and molecular innate immune tolerance.

Authors:  Katherine A Michaelis; Mason A Norgard; Peter R Levasseur; Brennan Olson; Kevin G Burfeind; Abigail C Buenafe; Xinxia Zhu; Sophia Jeng; Shannon K McWeeney; Daniel L Marks
Journal:  Brain Behav Immun       Date:  2019-09-06       Impact factor: 7.217

8.  Peripheral Adenosine A3 Receptor Activation Causes Regulated Hypothermia in Mice That Is Dependent on Central Histamine H1 Receptors.

Authors:  Jesse Lea Carlin; Dilip K Tosh; Cuiying Xiao; Ramón A Piñol; Zhoumou Chen; Daniela Salvemini; Oksana Gavrilova; Kenneth A Jacobson; Marc L Reitman
Journal:  J Pharmacol Exp Ther       Date:  2015-11-25       Impact factor: 4.030

9.  Inhibition of keratinocyte proliferation by phospholipid-conjugates of a TLR7 ligand in a Myc-induced hyperplastic actinic keratosis model in the absence of systemic side effects.

Authors:  Brian Crain; Shiyin Yao; Vina Keophilaone; Victor Promessi; McNancy Kang; Alcide Barberis; Roberto Maj; Emanuela Mura; Nadia Passini; Johanna Holldack; Ricardo Ochoa; Howard B Cottam; Dennis A Carson; Tomoko Hayashi
Journal:  Eur J Dermatol       Date:  2013 Sep-Oct       Impact factor: 3.328

10.  Synthesis and immunological characterization of toll-like receptor 7 agonistic conjugates.

Authors:  Michael Chan; Tomoko Hayashi; Crystal S Kuy; Christine S Gray; Christina C N Wu; Maripat Corr; Wolfgang Wrasidlo; Howard B Cottam; Dennis A Carson
Journal:  Bioconjug Chem       Date:  2009-06       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.